Awards & Advancement

HeartWare International appoints Katrin Leadley chief medical officer

Monday, August 4, 2014 03:48 PM

HeartWare International, an innovator of less invasive, miniaturized circulatory support technologies for advanced heart failure, has appointed Katrin Leadley, M.D., as chief medical officer of HeartWare, effective September 1. Leadley brings to HeartWare extensive strategic leadership, with more than 20 years of clinical and industry experience at life sciences firms, including QuintilesBoston Scientific and JenaValve Technology in Munich, where she spent the last three years as chief medical officer leading the company's clinical, regulatory, scientific and medical activities.

More... »

WIRB Copernicus Group

ibidi awarded with seal of quality

Monday, August 4, 2014 03:44 PM

The German Stifterverband, an association that promotes science and education in Germany, has awarded ibidi with their seal of quality for the company's ongoing and focused commitment to research and development.

More... »


INC Research appoints Jan Schreur senior vice president, human resources

Thursday, July 31, 2014 01:22 PM

INC Research, a global phase I to IV CRO, has appointed Jan Schreur as the company's senior vice president, human resources. Schreur brings nearly 30 years of progressive human resources experience to the role, including senior leadership positions at global biopharmaceutical organizations.

More... »

Rho named a Best Place to Work by Triangle Business Journal

Thursday, July 31, 2014 11:36 AM

Rho, a CRO focused on bringing new products to market through a full range of product development services, has been named by Triangle Business Journal a winner of Best Places to Work. The award is part of the publication's annual Best Places to Work Awards program and recognizes Rho’s achievements in creating a positive work environment that attracts and retains employees through a combination of benefits, working conditions and company culture.

More... »

Amy Schulman joins Polaris Partners

Thursday, July 31, 2014 11:24 AM

Polaris Partners has hired biopharmaceutical executive Amy Schulman as a venture partner, based out of Boston, Mass. Schulman, who most recently was general counsel, executive vice president and business unit lead of Pfizer consumer healthcare, will apply decades of experience to the Polaris healthcare portfolio. She also will assume the role of CEO of Arsia Therapeutics, an early stage Polaris-backed company co-founded by Dr. Robert Langer and Polaris partner Alan Crane. 

More... »

David Hall joins Rho as principal investigator of bioinformatics

Wednesday, July 23, 2014 08:00 AM

Rho, a privately held CRO focused on bringing new products to market through a full range of product development services, has announced that David Hall has joined its team as a principal investigator (PI) specializing in bioinformatics at its Research Triangle Park headquarters in North Carolina. David brings more than 12 years of experience in bioinformatics as a principal investigator, general manager, project manager, bioinformatics lead, programmer/analyst, data modeler and software engineer. 

More... »

Aptuit names Paul Overton EVP, business development & marketing

Tuesday, July 22, 2014 08:00 AM

Aptuit, a provider of integrated early to mid-phase drug development services, has appointed Paul D. Overton, Ph.D., executive vice president, business development and marketing, making him responsible for all of Aptuit's sales and marketing activities.

More... »

Evidera appoints Xavier Badia senior research and market development leader

Monday, July 21, 2014 08:03 AM

Evidera, a global provider of health economics, outcomes research, market access, data analytics and epidemiology solutions, has announced the addition of Xavier Badia, M.D., M.P.H., Ph.D. Badia will be senior research leader and senior leader of market development for the growing Evidera team in Europe.

More... »

INC Research names Carol Aliyar senior vice president, study start-up

Thursday, July 17, 2014 12:20 PM

INC Research, a global phase I to IV CRO has announced the promotion of Carol Aliyar to senior vice president, study start-up. Aliyar will be responsible for leading the company¹s global site engagement and study start-up efforts, including study start-up operations, site identification, site start-up and activation, ethics and regulatory submissions/approval and patient recruitment. Aliyar will focus on fostering strong site relationships to optimize timelines and deliver rapid study start-up for global clinical trials, establishing the foundation for successful collaboration across the duration of a study.

More... »

Covance adds two to clinical development services leadership team

Monday, July 14, 2014 01:04 PM

Covance has announced two key additions to its clinical development services scientific leadership team with the appointments of Robert Wasserman, M.D., as vice president and global therapeutic area head, oncology, and Rogelio Mosqueda-Garcia, M.D., Ph.D., as global vice president, early clinical services within medical and scientific affairs. Both are based in Princeton, N.J.

More... »

Subscribe to The CenterWatch Monthly
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

August 25

Verizon Communications enters clinical trial space with technology, network, and cloud and data services

Sponsors look to the power of genomic profiling to screen, enroll patients in trials for targeted therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs